$ARKG monthly Nobody cares about this ETF Yet it's a high-risk genomics ETF and thus suited to assess the current market environment It's currently breaking above the second-largest positioning shelf which has been acting as strong resistance It's also performing a breakout

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned